Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone regulating appetite and blood sugar. Clinical trials show that patients using semaglutide experience reduced food cravings within the first week, though visible weight loss usually emerges after the first 14 days of consistent use. Understanding this timeline helps set realistic expectations for your personalized weight loss journey.

When Semaglutide Starts Working: The First Week

Most patients notice changes in appetite during days 2 to 5 of starting semaglutide injection. These early signals come from the medication binding to GLP-1 receptors in your brain's appetite center, reducing the urge to eat large portions. Some people report feeling full faster at meals or losing interest in snack foods they previously craved.

Gastrointestinal adjustments often appear in week one as well. Your digestive tract is learning to process food more slowly, which contributes to the appetite-suppressing effect but may cause mild nausea or changes in bowel habits. These sensations typically peak during days 3 to 7 and gradually improve as your body adapts to the medication.

Measurable Weight Loss Timeline: Weeks 2 Through 4

The first visible weight loss usually appears between days 10 and 14 of treatment, though some patients report changes earlier depending on starting dose and individual metabolism. By the end of week three, most people using semaglutide experience a noticeable reduction in total body weight, ranging from 2 to 5 pounds for the first month. This initial drop reflects both reduced calorie intake and improved metabolic signaling.

Week four marks the point where patients often report higher confidence in their treatment plan. Consistent appetite suppression combined with behavioral adjustments creates momentum toward sustained weight loss. Clinical evidence suggests that dose increases during months 2 and 3 amplify weight loss acceleration, with optimal results appearing around week 8 to 12 when patients reach their target maintenance dose.

Factors That Influence How Quickly Semaglutide Works

Your genetic makeup plays a significant role in how your body responds to semaglutide. Key genetic variants in the GLP1R gene (such as rs6923761) and the FTO gene (rs9939609) affect how efficiently your body recognizes the medication and processes appetite signals. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to reveal your unique response profile, helping your provider optimize your treatment strategy from day one.

Starting dose, body composition, prior weight loss attempts, and dietary habits all influence response timing. Patients beginning at lower doses experience appetite changes gradually, while those starting at higher initial doses may notice effects more quickly. Additionally, individuals with higher baseline insulin resistance may see earlier metabolic improvements, even before scale weight drops significantly.

Three-Month Progress: Sustained Weight Loss With Compounded Semaglutide

By week 12, most patients using semaglutide injections have lost between 8 and 15 percent of their starting body weight, depending on adherence and lifestyle factors. This three-month checkpoint is when the medication's effects stabilize at consistent doses, and many providers reassess whether dose increases are necessary to maintain momentum. PlexusDx compounded semaglutide starts at $149 per month, making it accessible for continuous three-month evaluation without flat per-compound pricing increases.

Long-term success with semaglutide depends on maintaining consistent injection schedules, practicing portion control, and staying hydrated. Patients who combine medication with moderate exercise and balanced nutrition achieve the most dramatic results by month four and beyond. Many report that the appetite-suppressing effect remains reliable throughout treatment, allowing them to sustain weight loss without returning to previous eating patterns.

PlexusDx Semaglutide Injection: Getting Started Today

PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies to all 50 states without requiring insurance or membership fees. Starting at $149 per month across all commitment tiers, PlexusDx ensures your dose may go up while your price stays flat—no surprise costs as your treatment progresses. Orders ship directly to you, and most patients begin experiencing appetite changes within the first week.

New patients can add the Precision Peptide Genetic Test ($99 add-on after the first month) to unlock personalized insights about their peptide metabolism, GIPR sensitivity, and MC4R pathway function. This genetic roadmap helps your provider make informed adjustments during months two through four, maximizing your individual response to semaglutide. HSA and FSA funds are accepted, making compounded semaglutide treatment financially flexible.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many days until I feel semaglutide working?

Most patients notice reduced appetite and early fullness signals between days 2 and 5 of starting semaglutide injection. Measurable weight loss typically begins appearing around day 10 to 14, though individual response varies based on genetics, starting dose, and baseline metabolism. PlexusDx patients can track these milestones with their provider to confirm treatment effectiveness.

Will I lose weight in the first week of semaglutide?

Appetite reduction begins immediately, but visible scale weight loss usually emerges after 7 to 14 days. The first week primarily involves your body adapting to medication signals and reduced food intake, which creates the foundation for steady weight loss in weeks two through four. Some patients report initial water weight reduction within the first five days.

What is the average weight loss per month on semaglutide?

Most patients experience 2 to 5 pounds of weight loss in month one, 4 to 8 pounds in month two, and 6 to 12 pounds in month three as doses reach therapeutic levels. Results depend on starting dose, adherence, diet quality, and exercise habits. Clinical trials show that sustained use over 12 weeks typically produces 8 to 15 percent total body weight reduction.

Does semaglutide work better at higher doses?

Higher doses generally produce stronger appetite suppression and greater weight loss, but PlexusDx starts at $149 per month regardless of dose level—your price remains flat as doses increase. Your provider adjusts dosing based on your response and tolerance, not cost considerations. Most patients reach optimal results by week 8 to 12 when they reach their target maintenance dose.

Can the Precision Peptide Genetic Test predict how fast I'll lose weight?

PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways, including GLP1R variants (rs6923761), FTO variants (rs9939609), GIPR variants (rs1800437), and MC4R variants (rs17782313) that directly influence semaglutide responsiveness. These genetic insights help your provider anticipate your timeline, optimize your starting dose, and plan dose escalation for maximum individual results. The test costs $99 as an add-on after your first month of treatment.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves